- Home
- FLC vs ARAY Comparison
FLC vs ARAY Comparison
Compare FLC & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLC
- ARAY
- Stock Information
- Founded
- FLC 2003
- ARAY 1990
- Country
- FLC United States
- ARAY United States
- Employees
- FLC N/A
- ARAY N/A
- Industry
- FLC Trusts Except Educational Religious and Charitable
- ARAY Medical/Dental Instruments
- Sector
- FLC Finance
- ARAY Health Care
- Exchange
- FLC Nasdaq
- ARAY Nasdaq
- Market Cap
- FLC 180.6M
- ARAY 180.0M
- IPO Year
- FLC N/A
- ARAY 2007
- Fundamental
- Price
- FLC $16.70
- ARAY $2.14
- Analyst Decision
- FLC
- ARAY Strong Buy
- Analyst Count
- FLC 0
- ARAY 1
- Target Price
- FLC N/A
- ARAY $9.00
- AVG Volume (30 Days)
- FLC 37.8K
- ARAY 603.0K
- Earning Date
- FLC 01-01-0001
- ARAY 01-29-2025
- Dividend Yield
- FLC 6.64%
- ARAY N/A
- EPS Growth
- FLC N/A
- ARAY N/A
- EPS
- FLC N/A
- ARAY N/A
- Revenue
- FLC N/A
- ARAY $444,204,000.00
- Revenue This Year
- FLC N/A
- ARAY $6.64
- Revenue Next Year
- FLC N/A
- ARAY $5.69
- P/E Ratio
- FLC N/A
- ARAY N/A
- Revenue Growth
- FLC N/A
- ARAY N/A
- 52 Week Low
- FLC $12.62
- ARAY $1.40
- 52 Week High
- FLC $15.45
- ARAY $2.99
- Technical
- Relative Strength Index (RSI)
- FLC 47.98
- ARAY 58.64
- Support Level
- FLC $16.56
- ARAY $1.76
- Resistance Level
- FLC $16.89
- ARAY $2.29
- Average True Range (ATR)
- FLC 0.22
- ARAY 0.13
- MACD
- FLC 0.01
- ARAY 0.03
- Stochastic Oscillator
- FLC 57.00
- ARAY 71.70
About FLC Flaherty & Crumrine Total Return Fund Inc
Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.